Impact of metabolic syndrome on in-stent restenosis and clinical outcomes after percutaneous coronary stent implantation

Jeong Su Kim, Han Cheol Lee, Bo Kyung Choi, Hye Won Lee, Jin Sup Park, Yong Hwan Lee, Min Soo Ahn, Taek Jong Hong, Sang Pil Kim, Sang Kwon Lee, Yeong Dae Kim

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

We investigated the impact of metabolic syndrome (MS) on the occurrence of in-stent restenosis (ISR) and long-term major adverse cardiac events (MACEs), including cardiovascular death, myocardial infarction, and target vessel revascularization (TVR) during a follow-up period of 36 months after percutaneous coronary intervention (PCI) with stent implantation in patients with significant preexisting coronary artery disease. MS was not an independent predictor of increased ISR and MACE after PCI.

Original languageEnglish
Pages (from-to)e38-e41
JournalDiabetes Research and Clinical Practice
Volume88
Issue number3
DOIs
Publication statusPublished - 2010 Jun

All Science Journal Classification (ASJC) codes

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Fingerprint Dive into the research topics of 'Impact of metabolic syndrome on in-stent restenosis and clinical outcomes after percutaneous coronary stent implantation'. Together they form a unique fingerprint.

  • Cite this

    Kim, J. S., Lee, H. C., Choi, B. K., Lee, H. W., Park, J. S., Lee, Y. H., Ahn, M. S., Hong, T. J., Kim, S. P., Lee, S. K., & Kim, Y. D. (2010). Impact of metabolic syndrome on in-stent restenosis and clinical outcomes after percutaneous coronary stent implantation. Diabetes Research and Clinical Practice, 88(3), e38-e41. https://doi.org/10.1016/j.diabres.2010.03.024